Is the Symptom of Cough in Chronic Obstructive Pulmonary Disease Important?

References

• Afonso AS, Verhamme KM, Sturkenboom MC, et al. COPD in the general population: prevalence, incidence and survival. Respir Med. 2011;105(12):1872–1884. DOI:10.1016/j.rmed.2011.06.012
   PubMed Web of Science ®Google Scholar
• Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. DOI:10.1164/rccm.200612-1749OC
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. DOI:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Zhong NS, Zeng GQ. Prevention and treatment of chronic respiratory diseases in China. Chronic Dis Transl Med. 2019;5(4):209–213. DOI:10.1016/j.cdtm.2019.12.006
   PubMedGoogle Scholar
• Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136. DOI:10.1183/13993003.01136-2019
   PubMed Web of Science ®Google Scholar
• Irwin RS, Madison JM. The diagnosis and treatment of cough. N Engl J Med. 2000;343(23):1715–1721. [ DOI:10.1056/NEJM200012073432308
   PubMed Web of Science ®Google Scholar
• Sutradhar I, Das Gupta R, Hasan M, et al. Prevalence and risk factors of chronic obstuctive pulmonary disease in Bangladesh: a systematic review. Cureus. 2019;11(1):3970–3985.
   PubMed Web of Science ®Google Scholar
• Cho PSP, Fletcher HV, Turner RD, et al. The relationship between cough reflex sensitivity and exacerbation frequency in chronic obstructive pulmonary disease. Lung. 2020;198(4):617–628. DOI:10.1007/s00408-020-00366-x
   PubMed Web of Science ®Google Scholar
• Kim V, Criner GJ. The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. Curr Opin Pulm Med. 2015;21(2):133–141. DOI:10.1097/MCP.0000000000000145
   PubMed Web of Science ®Google Scholar
• Bowler RP, Kim V, Regan E, et al. Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest. 2014;146(4):941–950.
   PubMed Web of Science ®Google Scholar
• Corhay JL, Vincken W, Schlesser M, et al. Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study. Int J Clin Pract. 2013;67(12):1294–1301. DOI:10.1111/ijcp.12248
   PubMed Web of Science ®Google Scholar
• Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax. 2008;63(9):768–774. DOI:10.1136/thx.2007.093724
   PubMed Web of Science ®Google Scholar
• de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med. 2007;175(1):32–39. DOI:10.1164/rccm.200603-381OC
   PubMed Web of Science ®Google Scholar
• Putcha N, Drummond MB, Connett JE, et al. Chronic productive cough is associated with death in smokers with early COPD. COPD. 2014;11(4):451–458. DOI:10.3109/15412555.2013.837870
   PubMedGoogle Scholar
• Deslee G, Burgel PR, Escamilla R, et al. Impact of current cough on health-related quality of life in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2091–2097. DOI:10.2147/COPD.S106883
   PubMed Web of Science ®Google Scholar
• Koo HK, Park SW, Park JW, et al. Chronic cough as a novel phenotype of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:1793–1801. DOI:10.2147/COPD.S153821
   PubMed Web of Science ®Google Scholar
• Stephenson JJ, Cai Q, Mocarski M, et al. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:577–586. DOI:10.2147/COPD.S76157
   PubMed Web of Science ®Google Scholar
• Burge AT, Lee AL, Kein C, et al. Prevalence and impact of urinary incontinence in men with chronic obstructive pulmonary disease: a questionnaire survey. Physiotherapy. 2017;103(1):53–892. DOI:10.1016/j.physio.2015.11.004
   PubMed Web of Science ®Google Scholar
• Button BM, Holland AE, Sherburn MS, et al. Prevalence, impact and specialised treatment of urinary incontinence in women with chronic lung disease. Physiotherapy. 2019;105(1):114–1038. DOI:10.1016/j.physio.2018.07.006
   PubMed Web of Science ®Google Scholar
• Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012;12(1):26. DOI:10.1186/1471-2466-12-26
   PubMedGoogle Scholar
• Wang DY, Ghoshal AG, Razak BAMA, et al. Cough as a key symptom in asthma, allergic rhinitis, COPD and rhinosinusitis and its impact in Asia. Value Health. 2014;17(7):776–777.
   Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. DOI:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Landt E, Colak Y, Lange P, et al. Chronic cough in individuals with COPD: a population-based cohort study. CHEST. 2020;25(20):30130–30136.
   Google Scholar
• Lindberg A, Sawalha S, Hedman L, et al. Subjects with COPD and productive cough have an increased risk for exacerbations and death. Respir Med. 2015;109(1):88–95. DOI:10.1016/j.rmed.2014.12.001
   PubMed Web of Science ®Google Scholar
• Ekberg-Aronsson M, Pehrsson K, Nilsson JA, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res. 2005;6:98. DOI:10.1186/1465-9921-6-98
   PubMed Web of Science ®Google Scholar
• Crooks MG, Brown T, Morice AH. Is cough important in acute exacerbations of COPD? Respir Physiol Neurobiol. 2018;257(257):30–35. DOI:10.1016/j.resp.2018.02.005
   PubMedGoogle Scholar
• Cho SH, Lin HC, Ghoshal AG, et al. Respiratory disease in the Asia-Pacific region: cough as a key symptom. Allergy Asthma Proc. 2016;37(2):131–140. DOI:10.2500/aap.2016.37.3925
   PubMed Web of Science ®Google Scholar
• Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264–272. DOI:10.1183/09031936.00051110
   PubMed Web of Science ®Google Scholar
• Battaglia S, Benfante A, Principe S, et al. Urinary incontinence in chronic obstructive pulmonary disease: a common co-morbidity or a typical adverse effect? Drugs Aging. 2019;36(9):799–806. DOI:10.1007/s40266-019-00687-4
   PubMed Web of Science ®Google Scholar
• Hrisanfow E, Hagglund D. Impact of cough and urinary incontinence on quality of life in women and men with chronic obstructive pulmonary disease. J Clin Nurs. 2013;22(1–2):97–105. DOI:10.1111/j.1365-2702.2012.04143.x
   PubMed Web of Science ®Google Scholar
• Irwin GM. Urinary incontinence. Prim Care. 2019;46(2):233–242. DOI:10.1016/j.pop.2019.02.004
   PubMed Web of Science ®Google Scholar
• Berkhof FF, Doornewaard-ten Hertog NE, Uil SM, et al. Azithromycin and cough-specific health status in patients with chronic obstructive pulmonary disease and chronic cough: a randomised controlled trial. Respir Res. 2013;14(1):125–128. DOI:10.1186/1465-9921-14-125
   PubMedGoogle Scholar
• Monz BU, Sachs P, McDonald J, et al. Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis. Respir Med. 2010;104(4):534–541. DOI:10.1016/j.rmed.2009.10.026
   PubMed Web of Science ®Google Scholar
• Crooks MG, den Brinker A, Hayman Y, et al. Continuous cough monitoring using ambient sound recording during convalescence from a COPD exacerbation. Lung. 2017;195(3):289–294. DOI:10.1007/s00408-017-9996-2
   PubMed Web of Science ®Google Scholar
• Berkhof FF, Boom LN, Hertog NET, et al. The validity and precision of the leicester cough questionnaire in COPD patients with chronic cough. Health Qual Life Outcomes. 2012;10(1):4. DOI:10.1186/1477-7525-10-4
   PubMedGoogle Scholar
• Devries R, Kriebel D, Sama S. Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation. NPJ Prim Care Respir Med. 2016;6:16083.
   Google Scholar
• Asha H, Barry M, Erica Z, et al. Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI). Int J Chron Obstruct Pulmon Dis. 2018;13:1633–1645.
   PubMed Web of Science ®Google Scholar
• Hareendran A, Palsgrove AC, Schaefer ML, et al. The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2013;11(1):104. DOI:10.1186/1477-7525-11-104
   PubMedGoogle Scholar
• Leidy NK, Murray LT, Monz BU, et al. Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials. Respir Res. 2014;15(1):124. DOI:10.1186/s12931-014-0124-z
   PubMed Web of Science ®Google Scholar
• Mcgarvey L, Morice AH, Smith JA, et al. Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Resp Res. 2016;3(1):e000148. DOI:10.1136/bmjresp-2016-000148
   PubMed Web of Science ®Google Scholar
• Tagaya E, Yagi O, Sato A, et al. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD. Pulm Pharmacol Ther. 2016;39:81–84. DOI:10.1016/j.pupt.2016.06.008
   PubMed Web of Science ®Google Scholar
• Paggiaro PL, Dahle R, Bakran I, et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Lancet. 1998;351(9105):773–780. DOI:10.1016/S0140-6736(97)03471-5
   PubMed Web of Science ®Google Scholar
• Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003;361(9356):449–456. DOI:10.1016/S0140-6736(03)12459-2
   PubMed Web of Science ®Google Scholar
• Chong C-F, Chen CC, Ma HP, et al. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. Emerg Med J. 2005;22(6):429–432. DOI:10.1136/emj.2004.015719
   PubMed Web of Science ®Google Scholar
• Pelleg A, Xu F, Zhuang J, et al. DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough. Ther Adv Respir Dis. 2019;13:1753466619877960.
   Web of Science ®Google Scholar